NVIDIA stock makes headlines on a regular basis, but do you know how to pronounce the company's name? Does Jeff Bezos pronounce his own name "Bee-zos," evoking worker bees in hexagonal warehouses ...

Sanofi Healthcare Bidders Revising Offers Over Talc Concerns CD&R, PAI look to exclude aspects of Gold Bond unit in bids Consumer business could be valued at €15 billion in a sale ...

GSK Plc, Sanofi, and CSL Ltd. secured $72 million from the US government to ramp up production of bird flu vaccines as a nationwide outbreak among livestock and poultry has led to several human ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

A familiar face is currently in Florida this morning. "Fox & Friends" co-host Steve Doocy is at Harry and the Natives in Hobe Sound until 9 a.m., speaking to diners as part of the morning show's ...

Sanofi is of­fload­ing its rare au­toim­mune dis­ease med­i­cine En­jay­mo to an Ital­ian phar­ma­ceu­ti­cal com­pa­ny for $825 mil­lion up­front.

Now it’s trading hands again, through a deal announced Friday. Sanofi is selling global rights to Enjaymo to the Italy-based drugmaker Recordati, in exchange for an upfront payment of $825 million.

Recordati reached an agreement with French pharmaceutical company Sanofi to acquire the global rights to autoimmune disorder treatment Enjaymo for $825 million. The Italian pharmaceutical company ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as it considers whether to seek a sale or listing of the business. The ...

Sanofi SNY and partner Regeneron REGN announced that the FDA has approved their blockbuster drug, Dupixent, for its sixth indication — chronic obstructive pulmonary disease (COPD) — in the ...

3 spots in 2023. In their places are projected to be Novo Nordisk's (NVO) type 2 diabetes med Ozempic (semaglutide) and Regeneron Pharmaceuticals (NASDAQ:REGN)/Sanofi's (SNY) Dupixent (dupilumab ...